Proteomics approaches to characterize the immune responses in cancer.

Abstract

Despite the dynamic development of cancer research, annually millions of people die of cancer. The human immune system is the major 'guard' against tumor development. Unfortunately, cancer cells have the ability to evade the immune system and continue to grow. The proper understanding of the intricate immune response in tumorigenesis remains the holy grail of cancer immunology and designing effective immunotherapy. To decode the immune responses in cancer, in recent years, proteomics studies have received considerable attention. Proteomics studies focus on the detection and quantification of proteins, which are the effectors of biological functions, and as such, are proven to reflect the cell state more accurately, in comparison to genomic or transcriptomic studies. In this review, we discuss the proteomics studies applied to characterize the immune responses in cancer and tumor immune microenvironment heterogeneity. Further, we describe emerging single-cell proteomics approaches that have the potential to be applied in cancer immunity studies.

• Authors: Víctor Urbiola-Salvador, Dominika Miroszewska, Agnieszka Jabłońska, Talha Qureshi, Zhi Chen
• Journal: Biochimica et biophysica acta. Molecular cell research (Biochim Biophys Acta Mol Cell Res) Vol. 1869 Issue 8 Pg. 119266 (08 2022) ISSN: 1879-2596 [Electronic] Netherlands
• PMID: 35390423 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Topics

• Humans
• Immunity
• Immunotherapy
• Neoplasms (metabolism)
• Proteomics
• Tumor Microenvironment (genetics)